EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 59 filers reported holding EIDOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $584,000 | -70.0% | 4,435 | -89.1% | 0.00% | -100.0% |
Q2 2020 | $1,944,000 | +196.3% | 40,787 | +93.2% | 0.00% | +200.0% |
Q2 2019 | $656,000 | +115.8% | 21,110 | +62.7% | 0.00% | – |
Q1 2019 | $304,000 | -94.7% | 12,977 | -95.4% | 0.00% | -100.0% |
Q2 2018 | $5,705,000 | – | 280,469 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,123,630 | $55,047,000 | 23.98% |
Opaleye Management Inc. | 315,550 | $15,459,000 | 4.10% |
RA Capital Management | 2,162,671 | $105,949,000 | 3.35% |
Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,015,000 | 2.63% |
Cormorant Asset Management, LP | 1,100,000 | $53,889,000 | 2.50% |
Parkman Healthcare Partners LLC | 81,085 | $3,972,000 | 1.84% |
EAM Global Investors LLC | 38,535 | $1,888,000 | 1.10% |
Redmile Group, LLC | 689,478 | $33,778,000 | 0.95% |
Perceptive Advisors | 686,922 | $33,652,000 | 0.88% |
EAM Investors, LLC | 55,532 | $2,721,000 | 0.84% |